Another biological effect of tosylphenylalanylchloromethane (TPCK): it prevents p47phoxphosphorylation and translocation upon neutrophil stimulation
Open Access
- 8 March 2005
- journal article
- Published by Portland Press Ltd. in Biochemical Journal
- Vol. 386 (3) , 549-556
- https://doi.org/10.1042/bj20041475
Abstract
TPCK (tosylphenylalanylchloromethane), first discovered as a serine protease inhibitor, has been described to affect in diverse systems a number of physiological events probably unrelated to its antiprotease effect, such as proliferation, apoptosis and tumour formation. In the present study, we focus on its inhibition of the neutrophil respiratory burst, an important element of non-specific immunological defence. The superoxide anion-producing enzyme, NADPH oxidase, is quiescent in resting cells. Upon cell stimulation, the redox component, membrane-bound flavocytochrome b558, is activated when the cytosolic factors (p47phox, p67phox and p40phox, as well as the small GTPase Rac) associate with it after translocating to the membrane. This requires the phosphorylation of several p47phox serine residues. The signal transduction events leading to enzyme activation are not completely understood. In the past, the use of diverse protease inhibitors suggested that proteases were involved in NADPH oxidase activation. We suggested previously that TPCK could prevent enzyme activation by the phorbol ester PMA, not due to inhibition of a protease, but possibly to inhibition of the cytosolic factor translocation [Chollet-Przednowed and Lederer (1993) Eur. J. Biochem. 218, 83–93]. In the present work, we show that TPCK, when added to cells before PMA, prevents p47phox phosphorylation and hence its translocation; moreover, when PMA-stimulated cells are incubated with TPCK, p47phox is dephosphorylated and dissociates from the membrane. These results are in line with previous suggestions that the respiratory burst is the result of a series of continuous phosphorylation and dephosphorylation events. They suggest that TPCK leads indirectly to activation of a phosphatase or inactivation of a kinase, and provide the first clue towards understanding the steps leading to its inhibition of NADPH oxidase activation.Keywords
This publication has 68 references indexed in Scilit:
- Dephosphorylation of p53 during cell death by N-α-tosyl-l-phenylalanyl chloromethyl ketoneBiochemical and Biophysical Research Communications, 2003
- Disruption of 3-Phosphoinositide-dependent Kinase 1 (PDK1) Signaling by the Anti-tumorigenic and Anti-proliferative AgentN-α-tosyl-l-phenylalanyl Chloromethyl KetonePublished by Elsevier ,2001
- Serine protease inhibitor TPCK prevents Taxol-induced cell death and blocks c-Raf-1 and Bcl-2 phosphorylation in human breast carcinoma cellsOncogene, 1999
- Contrasting effects of calyculin A and okadaic acid on the respiratory burst of human neutrophilsEuropean Journal of Pharmacology: Molecular Pharmacology, 1995
- Identification of the N‐tosyl‐L‐phenylalanyl chloromethylketone modification site in Thermus thermophilus elongation factor TuFEBS Letters, 1989
- Parameters of activation of the membrane-bound O2• generating oxidase from bovine neutrophils in a cell-free systemBiochemical and Biophysical Research Communications, 1989
- N‐α‐Tosyl‐L‐lysine chloromethyl ketone and N‐α‐tosyl‐L‐phenylalanine chloromethyl ketone inhibit protein kinase CFEBS Letters, 1985
- Inhibition of neutrophil sulfhydryl groups by choloromethyl ketones a mechanism for their inhibition of superoxide productionBiochemical and Biophysical Research Communications, 1983
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976
- A new method for labelling the active center of chymotrypsinBiochemical and Biophysical Research Communications, 1962